Earth Science Tech, Inc. (ETST) Announces Second Quarter Fiscal 2023 Financial Results on November 14, 2022, Followed by Updated Conference Call and Webcast


Earth Science Technology, Inc.

Miami, Fla., Nov. 10, 2022 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a holding entity that is to acquire companies in the field of health and wellness currently in pharmaceutical compounding and telemedicine through its wholly-owned subsidiaries, announced today that the Company will report financial results for its second quarter of fiscal 2023 ended September 30, 2022 November 14, 2022 at 4:00 p.m. EST.

Updated conference call and Webcast:

The company will host a conference call and webcast to discuss its fiscal second quarter results, highlights and outlook at 5:00 p.m. Eastern Time. To join the conference call, please dial the number at least 15 minutes before the start time.

Login information for attendees only:

Toll-free number for participants:

800-267-6316 Primary

Direct/international participant:

203-518-9783 Alternate

Conference ID:


For those unable to attend, please email your questions to [email protected] The conference call will be recorded and accessible on the Investor Relations tab of the Company’s website.

About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”), a holding entity poised to acquire health and wellness companies currently in the pharmaceutical and telemedicine product pipeline through its wholly owned subsidiaries Proprietary, LLC. and Peaks Curative, LLC.

For more information, visit:

About, LLC., LLC. (“RxCompound”), is a compounding pharmacy that has historically focused on men’s health, particularly erectile dysfunction medical products such as tadalfil and sildenafil citrate (the generic names for Cialis and Viagra, respectively) and longevity. RxCompound is in the process of securing a sterile preparation room scheduled to launch in January 2023 to provide sterile products for injection.

To learn more, please visit:

About Peaks Curative, LLC.

Healing Peaks, LLC. (“Peaks”), is the go-to telemedicine site facilitating asynchronous consultations for brand-name compound drugs prepared at RxCompound. Peaks is in the final stages of upgrading its website after its soft launch and increasing its product offering. The full launch of Peaks is scheduled for January 2023.

To learn more, please visit:

SECURE DOOR ACT: Forward-looking statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial condition, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, management plans and objectives for our future operations, our CSE listing, including words such as “anticipate”, “if”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “could”, “should”, “will” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance or achievements differ materially from anticipated results, performance or achievements. We are under no obligation (and expressly disclaim any such obligation) to update or change our forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact:
Nickolas S. Tabraue
CEO and Director
[email protected]


Comments are closed.